NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $10,651,000 | +47.3% | 297,770 | +7.1% | 0.01% | +50.0% |
| Q3 2014 | $7,229,000 | -26.3% | 278,069 | -6.3% | 0.01% | -25.0% |
| Q2 2014 | $9,809,000 | +13.0% | 296,785 | +2.3% | 0.01% | 0.0% |
| Q1 2014 | $8,681,000 | +18.2% | 290,032 | +19.9% | 0.01% | +14.3% |
| Q4 2013 | $7,343,000 | +33.9% | 241,875 | +40.3% | 0.01% | +40.0% |
| Q3 2013 | $5,483,000 | +356.5% | 172,362 | +116.7% | 0.01% | +400.0% |
| Q2 2013 | $1,201,000 | +14.2% | 79,522 | -22.8% | 0.00% | 0.0% |
| Q1 2013 | $1,052,000 | – | 102,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|